Background Tinea capitis is the most common cutaneous fungal infection in children.
Introduction
Tinea capitis is a superficial cutaneous fungal infection or dermatophytosis of the scalp also referred to as ringworm. The infection originates from a variety of sources including humans, animals and soil. It remains the most common cutaneous fungal infection in children, most prevalent between 3 and 7 years of age. 1 The diagnosis of tinea capitis is made by a focused history, physical examination, trichoscopy and microscopy test. Methods of sample collection for microscopy diagnosis vary among location and investigator. The epidemiological distribution of tinea capitis has diverse geographical and seasonal variations depending on several factors, including lifestyle, population, migration of people and climatic conditions. This review aims to evaluate the differences between medications for the treatment of tinea capitis, to determine whether there are any significant adverse effects associated with this treatment and to determine the usefulness of the different diagnosing methods.
Methods

Search strategy and selection criteria
A systematic review examined randomized controlled trials (RCTs) and clinical trials of tinea capitis in children. No date ranges were set. Potentially relevant studies were identified through a literature search for articles published as of 1 June 2017, using multiple research databases (PubMed, Ovid, Scopus, Cochrane libraries and ClinicalTrials.gov). The search identified any citations containing 'tinea capitis' or 'ringworm of the scalp' and 'children, child or children, childhood or paediatric or young'. Additional limits included removing duplicates, and searches were limited to English only articles, humans and children aged 18 years or younger. References within retrieved articles were also searched to identify additional articles that may have been missed in the primary database search.
Study eligibility
Studies were selected for analysis if the following criteria were met: (a) clinical trial (CT) or RCT (b) participants were 18 years of age or younger; (c) tinea capitis was clinically (as defined by investigators) and mycologically (as defined by mycological testing) diagnosed and (d) reported efficacy rates (e.g. mycological cure, clinical cure, complete cure) and/or safety measures. Papers which met explicit inclusion criteria were included for full-text review.
Evaluation of efficacy
Primary measures were efficacy rates examined across eligible studies and included mycological cure, clinical cure and complete cure. Mycological cure was defined as negative mycological testing (e.g. negative culture, negative potassium hydroxide (KOH), periodic acid-Schiff stain (PAS)). Clinical cure was defined as the absence of signs and symptoms of tinea capitis (could be Total Signs and Symptoms (TSSS) score of 0 or a clinical parameter score of 0). Complete cure was defined as both mycological and clinical cure. The TSSS is a scale that rates the severity of 5 different signs and symptoms (erythema, desquamation/scaling, papules, pustules and pruritus) on a 4-point scale (0, absent; 1, mild; 2, moderate; 3, severe). These were summed to obtain a TSSS, with a maximum value of 15 points. 2 Secondary measures were qualitative evaluation of frequency and severity of reported adverse events and were obtained for each antifungal drug across all included studies. Study characteristics such as the year, location, method of collecting samples for investigation and infecting organisms were also reported and analysed.
Results
Study characteristics
Our search yielded 4190 studies (Fig. 1) . The most common organisms found in each continent were T. violaceum in Africa, fluconazole) were examined in 3998 children. [4] [5] [6] [7] [8] [9] [10] [13] [14] [15] [16] [17] [18] 20, 21, 24, 25, [27] [28] [29] [32] [33] [34] [35] [36] [37] [38] [39] [40] A few included studies also evaluated the efficacy and safety of combinations of oral and topical therapies across a total of 833 treated children 11, 12, 18, 19, 22, 23, 26, 30, 31 and 25 children used only topical therapies. 3 
Efficacy rates
Terbinafine was evaluated in twelve included studies using weighted averages 4, [7] [8] [9] [10] 15, 16, 20, 24, [37] [38] [39] with a pooled total of 1592 children ( 28 One RCT reported the species Penicillium and Scopulariopsis for the treatment with ketoconazole with only two participants and 100% mycological cure rate. 28 One topical treatment squalamine was tested in the Microsporum species with none of the five participants cured. 3 Griseofulvin more effectively treated Microsporum than Trichophyton infections (mycological cure rate 60% and 54%, complete cure rate 49% and 40%, respectively) ( Table 3 ). This is further improved with the combination of selenium shampoo to oral griseofulvin (mycological cure 61% and 31%, respectively). Fluconazole was equally effective in treating both Microsporum and Trichophyton infections (mycological cure 94% and 100%, respectively). Lastly, Trichophyton infections were more effectively cured than Microsporum with continuous itraconazole (mycological Tinea capitis in children cure 91% and 74%, respectively) and terbinafine (mycological cure 66% and 46%, complete cure 50% and 27%, clinical cure 69% and 40%, respectively). (Table 3) . No adverse events were considered life-threatening, and all were mild to moderate in severity and transient. Therefore, a total 318 children experienced some level of AEs related to drug use, at a frequency of 6.5% (318/4856). A total of 50 children ceased treatment 1.0% (50/4856) due to drug effects (Tables 4 and 5 ).
Adverse events reported
Discussion
Among the 75 different combinations of antifungal therapies identified in our literature search, continuous itraconazole and terbinafine had the highest mycological cure rates; griseofulvin and terbinafine had the highest clinical cure rates; and griseofulvin and terbinafine had the highest complete cure rate. Adverse events were transient and limited to mild to moderate in severity. Griseofulvin more effectively treated Microsporum than Trichophyton infections. Fluconazole was reasonably equally effective in treating both Microsporum and Trichophyton infections. Finally, Trichophyton infections were more effectively cured than Microsporum with continuous itraconazole and terbinafine. Traditionally, griseofulvin is the most widely prescribed medication for tinea capitis treatment in children, as it is one of the more cost-effective and accessible approaches. It is most effective for the treatment of Microsporum infections, but it is not available in paediatrics form in many countries. Table 6 outlines the paediatric drug availability per country. Microsized and ultramicrosized tablet versions of the drug show that co-administration of griseofulvin with fatty food will tend to reduce the difference between the bioavailability of the two types of preparations and microsized will be absorbed more easily. 41 Griseofulvin is fungistatic and is quickly eliminated from the body so it must be continuously given for a long period of time to be effective. This longer duration of treatment may also contribute to a higher level of adverse events experienced compared to agents such as itraconazole, ketoconazole and fluconazole. A higher dose of griseofulvin is also needed for endothrix infections than ectothrix. This may contribute to the reduction in patient compliance and decreased efficacy, specifically in children. Griseofulvin, itraconazole and fluconazole are available as liquid suspensions, and fluconazole is also available as suppositories which are preferable methods of treatment for young children who are unable to swallow capsules and tablets. After puberty, the incidence of tinea capitis becomes more infrequent as an increase in fungistatic and fungicidal saturated lipid acids is associated with puberty. 42 Azole antifungal agents itraconazole and fluconazole, as well as the allylamine agent terbinafine, have high affinity for keratinizing tissues, so these agents remain in keratin and hair for a period beyond the end of active dosing meaning dosage periods can be shorter than that of griseofulvin. Terbinafine for Microsporum infections needs to be given for a longer period of time, 6 to 8 weeks, compared to 4 weeks for Trichophyton infections. Oral terbinafine accounted for over half of the reported adverse events, possibly due to its extensive biodistribution. It is recommended that baseline transaminase is monitored in children taking terbinafine. 43 A 2016 Cochrane review concluded that the best evidence suggests that these newer treatments (terbinafine, itraconazole and fluconazole) have comparable results to griseofulvin in children with tinea capitis caused by Trichophyton species. 44 However, newer treatments are more expensive and as this is a fungal infection that generally infects the lower socio-economical communities of the world. Topical treatment may be useful as an adjunct to systemic therapy to decrease the carriage rate of infected species; however, oral treatment is necessary to effectively eradicate tinea capitis. 45 Treatments such as selenium sulphide, ketoconazole or ciclopirox shampoo are not FDA-approved for tinea capitis specifically; however, (likely as they are ineffective on their own) it can be applied 2 to 3 times per week and left in place for 5 to 10 min for the duration of therapy or at least 2 weeks. 45 Some experts recommend topical treatment is continued until clinical and mycological cure occurs. 45 Mycological cure should be interpreted with caution, as the presence of a topical antifungal in a culture media would likely lead to a false negative result, so a clinical confirmation is necessary. Bodyweight is used to determine drug dosing in most paediatric medicine to ensure a safe dose. Paediatric weight estimation methods have been varied due to problems with bias, precision and restrictions in the population to whom they can be applied. Physicians must rely on parental recall or provider estimation as strategies for estimating bodyweight or refer to the child's age or Tinea capitis in children length. 46 The effectiveness of these methods may be insufficient as most methods overestimate weight in children who are underweight and underestimate weight in children who are overweight or obese. 46 Additionally, these methods may not take into account the race and ethnicity of children. 46 More recent clinical trials have suggested that children require significantly larger weight-normalized doses to approximate the exposure estimates detected in adults. 47 Trichophyton tonsurans is the most common aetiology in North America, and recent data show that it accounts for the rise in the prevalence of tinea capitis. T. tonsurans is an anthropophilic dermatophyte more likely to infect human skin and hair and can maintain viability for extended periods on inanimate objects such as combs, brushes, sheets and blankets. The highest incidence of infection occurs between the ages 3 and 7 years old, and boys and girls are equally affected. 1 The continued rise of T. tonsurans as the primary cause of tinea capitis in North America can be attributed to a few factors. For one, the immigrant workers who have found their way into the USA, mostly from countries such as Mexico and Puerto Rico since the late 1890s, have been suspected to have carried the organism over the border. 48 Additionally, many physicians still consider fluorescence (Wood's light examination) to be synonymous with tinea capitis, and T. tonsurans does not show up with fluorescence and may not contain the classic appearance of black dots. This means many cases of tinea capitis are misdiagnosed as other scalp conditions (seborrhoea, dandruff and impetigo) and often inadequately treated, leading to spread of the infection. Microsporum canis is a zoophillic dermatophyte that causes infection carried by infected animals. It is the most common cause of tinea capitis in children in Europe, although cases due to anthropophilic dermatophytes such as M. audouinii, Trichophyton soudanense, Trichophyton violaceum are reported with increasing incidence since the 1990s.
Anthropophilic and zoophilic tinea capitis differ clinically, as the latter is characterized by more evident inflammatory changes. M. canis tinea capitis develops rapidly as a single round area of alopecia, with hair irregularly broken a few mm from the scalp, scales and erythema, associated with itching (Fig. 3) . The incidence is highest in hot months and history frequently reveals contact of the child with a wildcat. Tinea capitis due to anthropophilic dermatophytes, on the other hand, is often a chronic condition. Several small areas of alopecia due to hair broken at the scalp emergence (black dot tinea capitis) associated with mild scalp scaling are a typical feature (Fig. 4) . Scalp scaling associated or not with alopecia is found in family members, which should be checked and treated as they are asymptomatic carries. Trichoscopy confirms the diagnosis showing the typical features of tinea capitis, which vary depending on the hair type and not on the causative agent. 49 Comma hairs, corkscrew hairs and morse-code hairs are exclusive typical findings ( Fig. 3-4) . Of the techniques included in our review, the fastest way to diagnose tinea capitis is microscopy which provides confirmation of the diagnosis and establishes whether the fungus is smallspore or large-spore ectothrix or endothrix; however, it is not always the most accurate. Direct microscopy will not yield species identification, whereas culturing the scrapings will express the species in the sample, but it will not distinguish causative agents from contaminants. Culturing the scrapings should be done to confirm diagnosis and provide precise identification of the species for epidemiologic purposes, even though this takes extended time (approximately 3 weeks, or longer). 50 In the future, PCR-based techniques and DNA sequencings will be used more often as they are even faster than microscopy; they were not used in any of our included papers most likely due to the lack of availability of the necessary specialized equipment. Over half of the studies in this review used some form of the Wood's light examination as a way to initially diagnose the infecting organism; this method is of little significance in western countries as the majority of infections are due to T. tonsurans, which does not fluoresce. In North Africa and Europe, Microsporum infections still dominate and Wood's light may still be useful as it is the least invasive method of organism identification (Fig. 2) . Hair clippings are not mentioned as a form of collecting the sample in our literature search, this is probably due to the fact that not all hair is long enough or not all children want a section of their hair to be clipped. The hairbrush method has the least invasive and most accurate sample collection process. The cotton swab method was mentioned by one paper 38 and is similarly a good option as it is simple, inexpensive and useful for areas hard to scrape (eyelids, eyebrows) or areas that have lesions. The scalpel and hair plucking methods have better rates of identification; however, they are invasive specifically in children and particularly with active infected lesions. Diagnosis of inflammatory tinea capitis can sometimes be difficult as microscopy and even pathology might give negative results (Fig. 5a,b) . 51 Infection from fomites and hair care practices all play a role in the acquisition of tinea capitis due to anthropophilic dermatophytes. 1 Predisposing factors of this type of tinea capitis include large family size, crowded living conditions and low socio-economic status. 48, 50, 52 Individuals in contact with an infected person should be assessed for asymptomatic carriers of infection and may need to be treated to prevent spread of the infection. In case of tinea capitis by zoophilic dermatophytes, pets that may have carried the infection should be checked by a veterinarian, sampled by the toothbrush technique and treated accordingly, keeping in mind that cat can be asymptomatic carries of Microsporum canis. 53 Fomites that may be infected should be discarded or disinfected with bleach or hot soapy water to prevent infection. Recent studies have indicated that it is impractical to keep children recently treated with oral therapy out of the classroom, particularly those in higher grade levels, because shedding of spores can occur for months, despite therapy. 52 Tinea capitis, however, still remains a relatively rare entity among infants. One reference cites only 50 known reported cases of tinea capitis in infants less than 1 year of age at the time of their evaluation. 54 Guidelines for infant care are not established.
In conclusion, the importance of early diagnosis and proper treatment for children with tinea capitis cannot be overstated as the psychosocial impact of permanent baldness in a child's life, and the overall lower quality of health is substantial. Current dosing regimens of reported drugs are effective and safe for use in tinea capitis in children. Wood's light should not be used as the only method of organism identification; this study recommends the use of hairbrushes, toothbrushes or cotton swabs as viable alternatives. 
